Table 2.

Baseline data for heart rate, coronary flow, LV developed pressure, rate-pressure product, LV dP/dt_max, and LV dP/dt_min in control hearts for the experiments shown in Fig. 1

Experiment	Heart Rate, beats/min	Coronary Flow, ml/min	LV Developed Pressure, mmHg	Rate-Pressure Product, mmHg·beats·min−1	dP/dtmax, mmHg/s	dP/dtmin, mmHg/s
1. Effect of differing edema toxin doses*	262 ± 5	10.1 ± 0.3	95.3 ± 2.9	24,921 ± 768	3,697 ± 80	−1,816 ± 65
2. Effect of edema toxin inhibition with PA mAb†	277 ± 4	9.7 ± 0.3	86.1 ± 1.7	23,906 ± 587	2,888 ± 81	−1,658 ± 43
3. Effect of edema toxin inhibition with adefovir‡	289 ± 9	10.0 ± 0.3	96.0 ± 4.9	26,812 ± 1696	3,130 ± 116	1,667 ± 67

Values are means ± SE.

^*Controls included animals receiving diluents of edema toxin or PA alone.

^†Controls included animals receiving toxin diluents with PA-mAb, PA alone, or PA with PA mAb.

^‡Controls included animals receiving toxin diluents with adefovir or PA with diluents of adefovir.